
Multiple sclerosis - Symptoms and causes - Mayo Clinic
2024年11月1日 · People who have MS and who smoke tend to have more relapses, worse progressive disease, and worse cognitive symptoms. Women are up to three times as likely as men to have relapsing-remitting MS. The risk for MS in the general population is about 0.5%. If a parent or sibling has MS, your risk is about twice that or about 1%.
Multiple sclerosis - Diagnosis and treatment - Mayo Clinic
2024年11月1日 · Ask your healthcare team about your MS, including your test results, treatment options and, if you like, your prognosis. As you learn more about MS, you may become more confident in making treatment decisions. Keep friends and family close. Keeping your close relationships strong can help you deal with multiple sclerosis.
Multiple sclerosis - Care at Mayo Clinic
2024年11月1日 · Mayo Clinic's MS care teams evaluate thousands of people with MS each year. With a concentration on MS and vast experience, Mayo Clinic specialists are able to make accurate diagnoses and recommend effective treatments from the start. Because MS is less common in children than in adults, pediatric MS can be especially hard to diagnose.
Demyelinating disease: What can you do about it? - Mayo Clinic
2024年4月27日 · Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. In this disease, the immune system attacks the myelin sheath or the cells that produce and maintain it. The attack causes swelling, also known as …
Vitamins for MS: Do supplements make a difference?
2019年11月8日 · The connection between vitamin D and MS is supported by the association with exposure to sunlight and the risk of MS. There is a higher incidence and risk of MS in countries away from the equator. The Recommended Dietary Allowance (RDA) for adults is 600 international units (IUs) of vitamin D a day.
Emerging treatments for multiple sclerosis - Mayo Clinic
2024年7月3日 · Siponimod (Mayzent) was approved by the FDA in 2019. This tablet is taken orally and is approved for relapsing-remitting and secondary-progressive forms of MS. Siponimod is a medicine that stops certain cells that can cause damage in MS from entering the central nervous system. It also helps reduce both relapses and progression of disability.
Vitamin D and MS: Is there any connection? - Mayo Clinic
2025年2月26日 · MS develops when the immune system attacks the coating that protects the nerve cells, known as myelin. Research suggests that vitamin D has a positive effect on the immune system. Experts need to better understand how vitamin D might affect MS. There's also an association between sunlight exposure and the risk of MS. Sunlight is the body's most ...
Myelin oligodendrocyte glycoprotein antibody-associated disease …
2024年1月3日 · It may be mistaken for multiple sclerosis, known as MS. Or it may be confused with a condition called neuromyelitis optica spectrum disorder, also known as NMOSD. MOGAD is different from MS and NMOSD because the first attack of MOGAD is usually the most severe, but people with the disease can have a complete recovery.
Optic neuritis - Symptoms & causes - Mayo Clinic
2021年9月29日 · MS is a disease that causes inflammation and damage to nerves in your brain as well as the optic nerve. Besides MS, optic nerve inflammation can occur with other conditions, including infections or immune diseases, such as lupus. Rarely, another disease called neuromyelitis optica causes inflammation of the optic nerve and spinal cord.
Hypothermia - Symptoms and causes - Mayo Clinic
2024年4月16日 · Symptoms. When the temperature starts to drop, the body can start to shiver. Shivering is the body's attempt to warm itself.